Literature DB >> 19859055

Platelet adhesion and aggregation under flow using microfluidic flow cells.

Carolyn G Conant1, Michael A Schwartz, Tanner Nevill, Cristian Ionescu-Zanetti.   

Abstract

Platelet aggregation occurs in response to vascular injury where the extracellular matrix below the endothelium has been exposed. The platelet adhesion cascade takes place in the presence of shear flow, a factor not accounted for in conventional (static) well-plate assays. This article reports on a platelet-aggregation assay utilizing a microfluidic well-plate format to emulate physiological shear flow conditions. Extracellular proteins, collagen I or von Willebrand factor are deposited within the microfluidic channel using active perfusion with a pneumatic pump. The matrix proteins are then washed with buffer and blocked to prepare the microfluidic channel for platelet interactions. Whole blood labeled with fluorescent dye is perfused through the channel at various flow rates in order to achieve platelet activation and aggregation. Inhibitors of platelet aggregation can be added prior to the flow cell experiment to generate IC50 dose response data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19859055      PMCID: PMC3164058          DOI: 10.3791/1644

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  2 in total

1.  Activation of the GP IIb-IIIa complex induced by platelet adhesion to collagen is mediated by both alpha2beta1 integrin and GP VI.

Authors:  T Nakamura; J Kambayashi; M Okuma; N N Tandon
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 2.  The growing complexity of platelet aggregation.

Authors:  Shaun P Jackson
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

  2 in total
  15 in total

1.  Parallel-plate flow chamber and continuous flow circuit to evaluate endothelial progenitor cells under laminar flow shear stress.

Authors:  Whitney O Lane; Alexandra E Jantzen; Tim A Carlon; Ryan M Jamiolkowski; Justin E Grenet; Melissa M Ley; Justin M Haseltine; Lauren J Galinat; Fu-Hsiung Lin; Jason D Allen; George A Truskey; Hardean E Achneck
Journal:  J Vis Exp       Date:  2012-01-17       Impact factor: 1.355

2.  New device for high-throughput viability screening of flow biofilms.

Authors:  Michael R Benoit; Carolyn G Conant; Cristian Ionescu-Zanetti; Michael Schwartz; A Matin
Journal:  Appl Environ Microbiol       Date:  2010-04-30       Impact factor: 4.792

3.  Human neutrophil peptide-1 inhibits thrombus formation under arterial flow via its terminal free cysteine thiols.

Authors:  Jenny K McDaniel; Mohammad S Abdelgawwad; Audra Hargett; Matthew B Renfrow; Khalil Bdeir; Wenjing Cao; Douglas B Cines; X Long Zheng
Journal:  J Thromb Haemost       Date:  2019-03-13       Impact factor: 5.824

4.  The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.

Authors:  C Reiss; I Mindukshev; V Bischoff; H Subramanian; L Kehrer; A Friebe; J-P Stasch; S Gambaryan; U Walter
Journal:  Br J Pharmacol       Date:  2015-10-18       Impact factor: 8.739

5.  Systematic analysis of in vitro cell rolling using a multi-well plate microfluidic system.

Authors:  Oren Levy; Priya Anandakumaran; Jessica Ngai; Rohit Karnik; Jeffrey M Karp
Journal:  J Vis Exp       Date:  2013-10-16       Impact factor: 1.355

6.  Protective Mechanisms of S. lycopersicum Aqueous Fraction (Nucleosides and Flavonoids) on Platelet Activation and Thrombus Formation: In Vitro, Ex Vivo and In Vivo Studies.

Authors:  Eduardo Fuentes; Jaime Pereira; Marcelo Alarcón; Claudio Valenzuela; Pablo Pérez; Luis Astudillo; Iván Palomo
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-16       Impact factor: 2.629

7.  Mauritia flexuosa Presents In Vitro and In Vivo Antiplatelet and Antithrombotic Activities.

Authors:  Eduardo Fuentes; Wilson Rodríguez-Pérez; Luis Guzmán; Marcelo Alarcón; Simón Navarrete; Oscar Forero-Doria; Iván Palomo
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-18       Impact factor: 2.629

8.  Terminal platelet production is regulated by von Willebrand factor.

Authors:  Sonia Poirault-Chassac; Kim Anh Nguyen; Audrey Pietrzyk; Caterina Casari; Agnes Veyradier; Cecile V Denis; Dominique Baruch
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

9.  Bioassay-Guided Isolation and HPLC Determination of Bioactive Compound That Relate to the Antiplatelet Activity (Adhesion, Secretion, and Aggregation) from Solanum lycopersicum.

Authors:  Eduardo Fuentes; Ricardo Castro; Luis Astudillo; Gilda Carrasco; Marcelo Alarcón; Margarita Gutiérrez; Iván Palomo
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-13       Impact factor: 2.629

10.  Chlorogenic acid inhibits human platelet activation and thrombus formation.

Authors:  Eduardo Fuentes; Julio Caballero; Marcelo Alarcón; Armando Rojas; Iván Palomo
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.